In order to add to the still limited knowledge, we performed an exploratory analysis of a possible correlation between pre-vaccination Th17 cells, Tregs and MDSCs in peripheral blood with both vaccination induced T-cell responses as well as clinical outcome in metastatic melanoma patients vaccinated with survivin-derived peptides. The gene discussed is BIRC5; the disease is metastatic melanoma.